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1 Abstract 
Plant virus capsids have emerged as useful biotemplates for material synthesis. All plant virus 
capsids are assembled with high-precision, three-dimensional structures providing nanoscale 
architectures that are highly monodisperse, can be produced in large quantities and that 
cannot replicate in mammalian cells (so are safe). Such exceptional characteristics make plant 
viruses strong candidates for application as biotemplates for novel and new material 
synthesis.  
 
2 Introduction 
Bionanoscience, a sub-section of nanoscience, involves the exploitation of biomaterials, 
devices or methodologies on the nanoscale. It is multidisciplinary as it sits at the interface of 
chemistry, biology, physics, medicine, engineering and materials science. It is the 
combination of biology and nanotechnology that takes advantage of natural nanoparticles to 
create materials and devices on the nanoscale. Nanosystems may be produced by either 
micro-fabrication, making big structures smaller and/or by embedding smaller features into 
macroscopic materials (top-down), or by using the techniques of component assembly and/or 
supramolecular chemistry to make small molecules bigger (bottom-up). Biomaterials such as 
DNA, RNA, proteins, and viruses can be used as building templates for nanomaterials. 
Viruses in particular are of great interest to the nanotechnology field because of their highly 
monodisperse structures, small size, and the ability to self-assemble with high precession. 
 
2.1 Viruses  
The word virus is Latin and means poison. Viruses are obligate intracellular parasites, which 
only replicate within a host cell. Particles of simple (non-enveloped) virus typically consist of 
two components: one or more capsid proteins (shells) that assemble into precise three-
dimensional structures and genetic material. The genetic material is located in the interior of 
the capsid as circular, single-stranded or double-stranded fragments. Enveloped viruses 
possess a bi-lipid layer on the exterior that provides targeting specificity to the virus. Plant 
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and bacteria viruses (bacteriophages or phages) are not pathogenic to animals, so they are safe 
for use in materials science. The genome encodes the proteins necessary for the replication of 
the virus and the capsid protein(s); the capsid is mainly for the protection of the genetic 
material. Virus capsids also have roles in host cell targeting and cell entry [1]. Virus particles 
typically represent very stable structures that have evolved to withstand a broad range of 
environments yet are sensitive enough to release their nucleic acid when they infect a 
susceptible cell [2].  
 
2.2 Why virus nanoparticles (VNPs) 
Viruses are considered as protein cages, scaffolds and templates for the production of novel 
nanostructured materials on/in which organic and inorganic moieties can be incorporated in a 
very precise and controlled fashion. Genetic engineering (chimaeric technology) enables the 
insertion or replacement of selected amino acids on virus capsids for uses from 
bioconjugation to mineralization [3, 4]. Many virus coat proteins will assemble in vitro, 
naturally or after genetic manipulation, into non-infectious containers called virus-like 
particles (VLPs). Viruses can be found in a variety of distinct shapes, most commonly 
icosahedrons (sphere-like) and rod-shaped, Figure 1, though, especially in the case of 
bacteriophages, more complicated structures can be formed. 
 
Figure 1 
 
Plant viruses are non-infectious towards other organisms and they do not present a biological 
hazard. The production of the virus particles is simple and quick. When produced in the 
natural host, high expression yields can be achieved. For example, some plant virus particles 
can be obtained in gram scales from 1 kg of infected leaf material within 2–4 weeks [5]. 
Heterologous expression systems can also give rise to high yields of VLPs [6]. Viruses have 
unique properties: ease of functionalisation, ability to self-assemble, monodispersity, 
structural symmetry and the majority of viruses are stable over a wide range of pH and 
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temperatures. Further, they display a remarkable plasticity in their capsid structure and 
dynamics (coordinated assembly, disassembly and uniformity). Their amenability to genetic 
and chemical modification and diversity of sizes and shapes make them ideal work-horses 
with a variety of possible applications in nanotechnology. 
  
Many plant viruses, due to these properties, have been investigated for their potential use for 
material fabrication on the nano/microscale, including the icosahedral, sphere-like, viruses 
Cowpea chlorotic mottle virus (CCMV), Cowpea mosaic virus (CPMV), Brome mosaic virus 
(BMV), Cucumber mosaic virus (CMV), Red clover necrotic mosaic virus (RCNMV), 
Carnation mottle virus (CarMV) and Turnip yellow mosaic virus (TYMV), and the rod-
shaped Tobacco mosaic virus (TMV). Viruses offer three different surfaces that can be 
exploited: the exterior, the interior, and the interface between subunits, Figure 2. The inner 
cavity of the virus capsid is accessible to small molecules and impermeable to larger ones, 
which allows the use of the interior space of VLPs as nanotemplates and nanoreactors. 
Furthermore, the exterior surface is widely considered as a robust platform and is used for 
both chemical and genetic modification allowing multivalent ligand display. The virus 
architectural interface is crucial for assembly and offers another route for the manipulation of 
the capsid architecture.  
 
Figure 2 
 
2.3 Empty virus-like particles (VLPs)  
Virus-like particles (VLPs) are supramolecular structures that have the form of rods or 
icosahedrons with diameters in the range of 25–100 nm [7]. They are composed of multiple 
copies of one or more recombinantly expressed virus structural proteins that spontaneously 
assemble into particles upon expression. In addition to being virus-like in structure, they are 
often antigenically indistinguishable from the virus from which they were derived. VLPs 
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resemble viruses but are non-infections because they do not contain any virus genetic 
material.  
 
In vitro assembly and re-assembly methods have been exploited for VLPs. Generally, 
particles are exposed to a disassembly buffer followed by dialysis against an assembly buffer. 
These disassembly approaches allow the release of nucleic acid and are used to generate 
VLPs for encapsulating materials of interest on reassembly. VLPs of TMV and CCMV have 
been demonstrated to efficiently self-assemble in vitro [8]. Alternatively, an alkaline 
hydrolysis method was developed to extract nucleic acid from CPMV [9] to generate empty 
particles. Recently, a method for the production of large quantities of CPMV VLPs in plants 
has been developed [10]. The mature large (L) and small (S) proteins of the capsid structure 
are produced by the cleavage of the precursor (VP60) by the action of a virus-encoded 
proteinase (24K proteinase). CPMV VLP production takes advantage of the highly efficient 
plant transient expression system, pEAQ–HT [11, 12]. The pEAQ–HT system is used to 
simultaneously express the VP60 coat protein precursor and the 24K proteinase in plants via 
agroinfiltration. Efficient processing of VP60 to the L and S proteins occurs, leading to the 
formation of VLPs [10, 13]. CPMV VLPs possess the same structure as wild-type CPMV but 
lack the genetic material within the capsid, Figure 3. 
 
Figure 3 
 
Virus platforms including CCMV [14], TMV [15], MS2 bacteriophage [16] and polyoma 
virus-like particles (capsoids) [17] have been used as constrained reaction vessels for 
packaging and nucleation sites for mineralization [14, 18]. In addition, intact enzymes have 
been encapsulated within the CCMV capsid [19]. Further examples of the use of VLPs for the 
production on bionanomaterials will be presented later. 
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For RCNMV, the decoration of preformed synthetic nanoparticles with an origin of assembly 
site (OAS) that initiates coat protein monomer binding leads to self-assembled VLPs with 
synthetic nanoparticles within. Thiolated artificial OAS was attached to gold nanoparticles 
and the OAS-gold nanoparticles were mixed with RCNMV coat protein monomers. This 
templates the in vitro self-assembly of VLPs around the gold nanoparticle, Figure 4 [20]. This 
approach was expanded to include encapsulation of quantum dots with sizes of 5, 10, and 15 
nm [20, 21]. 
 
Figure 4 
 
Alternatively, a nanoparticle is coated with negatively charged polymers to mimic RNA, an 
approach which was pioneered by Dragnea’s group. Although citrate-stabilised gold 
nanoparticles resulted in VLPs encapsulating preformed gold nanoparticles the process was 
not efficient [22]. However, covalent functionalisation of nanoparticles with carboxyl-
terminated polyethylene glycol (PEG) [23, 24] was used to mimic RNA nucleation and 
promote efficient in vitro self-assembly, Figure 5. 
 
Figure 5 
 
 3 Tobacco mosaic virus (TMV) 
TMV is a rod-like plant virus consisting of 2130 asymmetric subunits arranged helically 
around a single-stranded RNA genome. Native TMV is 300 nm in length and 18 nm in 
diameter with a 4 nm cylindrical central cavity [25, 26], which can be purified from infected 
tobacco plants in large quantities. The surface properties of TMV have been chemically and 
genetically manipulated without affecting the virus integrity or morphology of the capsid. The 
highly polar outer and inner surfaces of TMV contain hydroxyl and deprotonated carboxylate 
groups [27]. TMV has been exploited as a template to grow metal or metal oxide 
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nanoparticles such as iron oxides, iron oxyhydroxides, cadmium sulfide, lead sulfide, gold, 
nickel, cobalt, silver, copper, CoPt, FePt, and silica. [28-32]. 
 
In order to achieve successful coating based on electrostatic interactions, the deposition 
conditions should be varied in order to match the interaction between the virion surface and 
the deposition precursor. In the case of silica coating, carrying out the reaction at a pH less 
than three results in a positively charged TMV surface that will have strong interactions with 
the anionic silicate sols formed by hydrolysis of tetraethoxysilane. In contrast, cadmium 
sulfide, lead sulfide and iron oxides can be successfully coated on the outer surface at near 
neutral pH by specific metal ion binding with glutamate and aspartate residues [33]. As for 
metal deposition, in some cases, a suitable activation agent is needed in order to realise 
successful coating; Pd(II) and Pt(II) are two typical activation agents. The metal deposition 
can occur either inside the inner channel or at the outer surface of TMV [34].  
 
Genetically engineered TMV can show enhanced deposition of metal onto its surface [35, 36]. 
Native TMV can be genetically altered to display multiple metal binding sites through the 
insertion of two cysteine residues within the amino-terminus of the virus coat protein. In situ 
chemical reductions successfully deposited silver, gold, and palladium clusters onto the 
genetically modified TMV without any activation agent [35]. Furthermore, mixing TMV with 
aniline and a mild oxidant resulted in highly uniform, micron length nanofibres measuring 
approximately 2 nm in diameter, likely due to the non-covalent interactions between aniline 
and TMV [36].  
 
The exterior and interior of TMV have been utilised for inorganic material synthesis via metal 
electroless deposition (ELD). The interior surface of TMV is negatively charged under 
physiological conditions, whereas the exterior surface exhibits positive charge [37]. The 
exterior of TMV was coated with cadmium sulfide, lead sulfide, amorphous iron oxide, silica 
[15], platinum and gold [38, 39]. Silver and copper can be incorporated inside the central 
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channel of TMV; the differential nucleation being electrostatically driven as a consequence of 
the difference in surface charges [40, 41]. In addition, TMV particles were engineered to 
encode unique cysteine residues (TMV1cys); this allowed the assembly of TMV1cys onto a 
gold patterned surface, the particles assembled in a vertically oriented fashion. The 
subsequent ELD resulted in uniform metal coatings up to 40 nm thick [42]. 
 
4 Cowpea chlorotic mottle virus (CCMV) 
CCMV is a member of the bromovirus group of the Bromoviridae family. The genome 
consists of three single-stranded, positive sense RNAs that are encapsidated separately. The 
capsid is composed of 180 asymmetric (identical) protein subunits (20.3 kDa each). CCMV 
particles are ~28 nm in diameter formed as an icosahedral shell. Virus can be obtained in high 
yields of 1-2 g of purified particles per 1 kg of infected plant tissue. In addition, yeast-based 
expression systems of the coat proteins have been developed that can assemble VLPs. For 
example, expression of CCMV in Pichia pastoris yields up to 0.5 mg per gram of wet cell 
mass [6]. Heterologous expression in yeast allows large-scale production of wild-type and 
genetically modified capsids or VLPs. The main advantage of heterologous expression is that 
it allows production of VLPs that would be unlikely to assemble and accumulate in the 
natural host cells. 
 
The structure of the wild-type and swollen forms of CCMV has been determined to 3.2 Å 
[43]. The exterior CCMV capsid electrostatic interactions are well studied [44]. These 
interactions provide a reversible method to control the assembled capsid structure. The native 
form of CCMV swells at a pH > 6.5 resulting in 60 pores of 2 nm in size, Figure 6, [2, 44, 
45]. The native genetic material can escape via the open pores leaving an empty nano-
container for the mineralization of polyoxometalate species, encapsulation of anionic 
polymers [2, 14] and the synthesis of gold nanoparticle cores [46]. 
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The self-assembly of a virus is initiated by electrostatic interactions between RNA and the 
protein subunits. In the case of CCMV, mixing the coat protein monomers with different 
sized polystyrenesulfonate (PSS) polymer to mimic the RNA resulted in two different size 
morphologies: 22 nm-sized particles generated by using PSS with molecular weight below 2 
MDa and 27 nm-sized particles with PSS of 2 MDa or higher [47]. CCMV can also be used 
for the synthesis of biohybrid nanostructures. It can be self-assembled with a polyethylene 
glycol (PEG) functionalised exterior surface and can then internalise PSS; expanding the 
possibilities for new types of hybrid virus nanomaterials [48]. In related work, Hibiscus 
chlorotic ringspot virus (HCRSV) particles have been used to encapsulate negatively charged 
polymers including PSS and polyacrylic acid. Reassembly yielded VLPs encapsulating the 
polymers. However, attempts to encapsulate neutral molecules such as fluorescein-labelled 
dextran failed, suggesting the encapsulation is based on electrostatic interactions [49]. 
 
Material encapsulation into assembled CCMV particles has been an active area of research. 
For example, the encapsulation of anionic polyanetholesulfonic acid (PASA) is controlled by 
pH-dependent gating of the CCMV pores [14]. Further, the entrapment of lanthanide ions [14] 
has been described. A similar approach has been adopted to infuse fluorescent dyes and drugs 
within RCNMV [50]. 
 
Figure 6  
 
The mineralization reaction within CCMV is electrostatically driven. The interior is highly 
positively charged and therefore provides an interface for inorganic nucleation. The 
negatively charged tungstate, WO4–, and vanadate, VO3–, anions interact with the interior 
capsid surface via electrostatic interactions [14]. The same principle was used to generate 
internalised titanium oxide (β-TiO2) [51] and Prussian blue nanoparticles [52]. Furthermore, 
the substitution of all the basic residues on the N-terminus of the coat protein with negatively 
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charged glutamic acid [6] resulted in the mutant favouring interaction with ferrous and ferric 
ions leading to the formation of magnetite (γ-Fe2O3) within the capsid [2]. 
 
5 Cowpea mosaic virus (CPMV) 
CPMV is a non-enveloped plant mosaic virus which is the type member of the comovirus 
genus of the family Comoviridae [53]. The virus is normally propagated in Vigna 
unguiculata, commonly known as cowpeas or black-eyed peas or beans. In the laboratory, the 
virus is introduced into the plant by means of mechanical inoculation, which results in mosaic 
and yellowing symptoms of the leaves. CPMV is considered one of the best investigated 
viruses and is widely used in bionanotechnology [54, 55]. CPMV capsids have pseudo T=3 
icosahedral symmetry and a diameter of approximately 28 nm. The CPMV capsid structure 
comprises 60 small coat proteins (S, domain A) which folds into one jelly roll β-sandwich 
arranged as 12 pentamers at the 5-fold axis and 60 large coat proteins (L, domains B and C) 
arranged as trimers at the 3-fold axis and fold into two jelly roll β-sandwich domains. The 
three domains form the asymmetric unit. The crystal structure is known to 2.8 Å resolution, 
Figure 7 [56]. CPMV is a single-stranded positive-sense bipartite RNA virus. Both of the 
separately encapsidated RNA segments are required for infection [57-59]. However, it was 
later demonstrated that RNA-1 is independently capable of replicating CPMV particles in 
protoplasts [60]. RNA-1 encodes the virus replication machinery as well as the virus 
proteinase and the virus protein genome-linked (VPg), which plays an essential role in 
initiating RNA synthesis. On the other hand, the smaller RNA-2 encodes the movement 
protein and the two capsid proteins.  
 
Figure 7  
 
CPMV particles produced during the infection process can be separated into three 
components on caesium chloride density gradients. These have identical protein 
compositions, but differ in their RNA contents [57]. The three centrifugal components are 
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termed top (T), middle (M), and bottom (B) and contain no RNA, RNA-2, and RNA-1, 
respectively, Figure 8 [57, 58, 61]. The three components generated during CPMV infection 
also exist as two electrophoretic forms, slow and fast, Figure 8 [62, 63]. The slow form can be 
converted to the fast form by proteolytic cleavage at the carboxyl (C)-terminus of the S 
protein [64, 65]. The conversion occurs naturally during infection, with the fast (C-terminally 
processed) form of the S protein predominating at later times [64]. Cleavage of the S protein 
was shown to occur after leucine189 resulting in the loss of the carboxyl-terminal 24 amino 
acids [10, 66].  
 
Figure 8  
 
Wild-type CPMV was first mineralized after appropriate genetic modification that involved 
the use of infectious cDNA clones to modify the capsid, thereby allowing the presentation of 
foreign peptides on the external CPMV surface [67-69]. It had been established that 
additional amino acids can be inserted into the highly surface exposed βB–βC loop of the 
small subunit of CPMV. CPMV-based chimaeric virus technology was then adapted for the 
environmentally benign synthesis of virus-templated monodisperse silica [3] and amorphous 
iron-platinum nanoparticles [4]. To avoid the lengthy process of generating chimaeric CPMV 
particles, and to avoid some of the disadvantages of the genetic engineering route (stability, 
reversion to wild-type and time taken), the possibility of chemically attaching peptides that 
promote specific mineralization to the surface of CPMV particles was investigated. Peptides 
previously identified by using phage display that specifically direct mineralization by CoPt 
(Cbz-CNAGDHANC), FePt (Cbz-HNKHLPSTQPLA), and zinc sulfide (Cbz-
CNNPMHQNC) were selected [70, 71] and chemically coupled to the surface exposed 
lysines, the PeptideCPMV was subsequently incubated with the corresponding metal salt and 
reductant to generate CoPt-CPMV, FePt-CPMV and ZnS-CPMV [72]. 
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The electroless deposition (ELD) method was developed as an alternative approach to 
generate metal coated virus particles based on the interaction of the CPMV surface amine 
groups with palladium ions acting as activator sites, which then formed palladium clusters 
after treatment with a reducing agent (dimethylamine borane). The clusters acted as 
nucleation sites for the subsequent adsorption of metal ions of interest to generate metal 
(nickel, cobalt, platinum, iron, nickel-iron, cobalt-platinum) coated CPMV particles. This 
allowed production of metallized CPMV nanoparticles with a size of 35 nm in diameter; 
although deposition time could be extended to produce larger metallized spheres [73].  
 
Furthermore, and importantly, it was subsequently shown that there is no requirement for the 
use of mineral/metal specific peptides or the electroless deposition process for the CPMV-
templated formation of monodisperse mineralized nanoparticles; it is sufficient to simply 
increase the virus surface negative charge. This is done by chemical modification of CPMV 
surface lysines with succinic acid to increase the overall negative charge on the virus capsid. 
The charge-modified CPMV, (SuccinamateCPMV), was coated with cobalt or iron oxide to give 
monodisperse nanoparticles of about 32 nm diameter. The iron oxide-CPMV nanoparticle 
surface can be functionalised further with, for example, oligosaccharides [74].  
 
When a cationic polyelectrolyte, poly(allylamine) hydrochloride (PAH), was electrostatically 
adsorbed onto the external surface of the CPMV capsid. The polyelectrolyte promotes the 
adsorption of anionic gold complexes, which were then easily reduced, under mild conditions, 
to form a metallic gold layer. The process is simple and environmentally friendly, as only 
aqueous solvent and ambient temperature and pressure are required. This route offers a way to 
produce Au-CPMV with a narrow size distribution which can be further modified with thiol 
containing moieties [75]. In contrast, reaction of polyelectrolyte-modified CPMV (PACPMV) 
with pre-formed gold nanoparticles resulted in the self-assembly of large, hexagonally 
packed, tessellated-spheres, Figure 9 [75]. 
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Figure 9  
 
Small lanthanide molecules have been infused and entrapped inside the wild-type CPMV 
cavity by taking advantage of the negatively charge RNA interaction with gadolinium(III), 
Gd3+, and terbium(III), Tb3+, cations; approximately 80 Gd3+ or Tb3+ ions can be encapsulated 
[76]. However, as the importance of VLPs became apparent, some attempts to inactivate or 
eliminate the virus RNA within CPMV capsids were reported, including UV irradiation (254 
nm) using a dosage of 2.0 – 2.5 Jcm-2. The inactivated particles were deemed as non-
infectious to plants. However, particles remained intact and maintained chemical reactivity 
[77]. Moreover, the RNA content remains encapsidated so that the internal cavity of the 
particles is not accessible for material loading. Alternatively, alkaline hydrolysis was used to 
generate artificial empty CPMV particles [9]. The majority of the particles remain intact 
during the disassembly step. In addition, these processes risk altering the structural properties 
of the particles and generally do not actually remove RNA from the particles. The recent 
development of a method for the production of large quantities of CPMV VLPs in plants, as 
described above [10], was the motivation behind the exploration of loading the generated 
CPMV VLPs with metal and metal oxide [78], dyes and drugs [79]. It was noticed that the 
efficiency of loading with metal proved to be variable and depended on the particular VLP 
preparation used. The role of the carboxyl (C) terminus of the small coat (S) protein in 
controlling access to the interior of the VLP has been investigated through the determination 
of the efficiency of internal mineralization with cobalt [63]. The presence of a C-terminal 24-
amino acid peptide of the S protein was found to inhibit internal loading, an effect that could 
be eliminated by enzymatic removal of this region with chymotrypsin. The amenability of the 
C-terminus to genetic modification has also been demonstrated. Substitution with six histidine 
residues generated stable particles and facilitated external mineralization by cobalt, Figure 10, 
[63].  
 
Figure 10  
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6 Modifying the virus surface 
The virus capsid surface can be addressed with a range of biological and chemical moieties. 
By doing so, a selection of functionalised nanobuilding blocks can be obtained. The external 
capsid surface of CCMV, CPMV and TYMV possess a large number of selectively 
addressable amino acids allowing decoration with a large number of molecules. The native 
viruses display amine groups, from lysine, and carboxylate groups derived from aspartic and 
glutamic acids. These functional groups (–NH2 or –COOH) on the surface offer a precise 
addressable site and are the most frequently used for chemical modification. This can be 
achieved using various techniques of covalent coupling [54, 80-85] and by “click”-chemistry, 
the copper(I)-catalysed azide-alkyne [3+2] cycloaddition reaction [86-89]. Both wild-type and 
genetic variants of CPMV have been used as scaffolds for chemical modification; early 
investigations of the chemical reactivity of wild-type CPMV were aimed at lysine- and 
cysteine-selective derivatives. The X-ray structure and coordinates of CPMV indicated the 
presence of five solvent-exposed lysines per asymmetric unit, which equates to 300 exposed 
lysine side chains per CPMV particle, Figure 11 [90]. In a study on CPMV, single, double, 
triple, and quadruple lysine-minus mutants, in which the addressable lysines were 
sequentially replaced with arginines, were generated and chemical labelling efficiency was 
measured. The studies indicated that all of the five lysines are available for functionalisation; 
the degree of labelling efficiency varies between the different sites, and normally only four 
per subunit are modified [83, 91]. The most reactive groups were found to be lysine 38 on the 
S protein and lysine 99 on the L protein [90].  
 
Carboxylates derived from aspartic and glutamic acids have also been utilised. Chemical 
attachment of amine-containing compounds can be achieved by making use of the coupling 
reagents 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N- hydroxysuccinimide. Up to 
180 surface addressable carboxylates per CPMV virion have been modified with different 
moieties [83, 92]. The native CPMV also displays two surface tyrosines per asymmetric unit 
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that are available for chemical conjugation [80]. For CCMV around 540 lysine residues and 
up to 560 carboxylates can be decorated [93]. In the case of TYMV, approximately 60 surface 
lysines and 90–120 carboxylate groups can be addressed [94]. 
 
Thiols derived from cysteine side chains are typically not found in a reactive form on the 
solvent-exposed surface of viruses; although, cysteine side chains have been identified on the 
interior solvent-exposed surface of CPMV [86, 95]. As thiols are nevertheless a useful group 
to use for conjugation a range of cysteine-mutant viruses have been generated via genetic 
modification [8, 95-101]. For CCMVCYS mutant about 100 of the 300 introduced cysteinate-
thiols can be labelled [93], for CPMVCYS mutant 60 cysteinate-thiols are introduced and 
addressed [95, 102]. As an alternative route to genetic modification for the introduction of 
thiol groups at the capsid surface a chemical method has been reported [103]. If required, 
histidines can be genetically engineered into the external surface [104].  
 
Figure 11  
 
The phenolic group of tyrosine side chains also provides a possible target for chemical 
modification. However, the phenolic group is only moderately reactive and to achieve 
conjugation the tyrosine has to be oxidised by one electron with, for example, peracid or 
persulfate reagents [105]. Commercial reagents are typically not available; therefore, the 
starting materials and coupling reagents must be chemically synthesised. The most common 
reaction utilising tyrosine side chains on viruses is diazonium coupling and this has been 
widely used with MS2 and TMV [106, 107]. CPMV particles display two accessible tyrosine 
side chains located in the S subunit, which are available for chemical modification; 
fluorescein has been covalently attached [80]. 
 
CPMV has been utilised to construct enzyme-modified functional virus particles. The well-
studied enzymes horseradish peroxidise (HRP) and glucose oxidase (GOX) were employed to 
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prepare EnzymeCPMV conjugates by their conjugation to the external surface of wild-type 
CPMV. These relatively large biomacromolecules can be bound to the virus surface by simple 
coupling strategies without destroying their biological activity. The number of enzymes 
bound to the surface of the virus was determined to be approximately 11 HRP and 2-3 GOX, 
respectively. The HRPCPMV and GOXCPMV particles have potential uses as building blocks 
for catalytic devices, diagnostic assays or biosensors [108]. 
 
Figure 12  
 
In this context, both carboxy- and amine-containing surface exposed amino acids have been 
modified with electroactive moieties. The incorporation of ferrocene to CPMV 
(FerroceneCPMV) provided nanostructures with well-defined sizes and functionalities [91]. 
Cyclic voltammetry established that FerroceneCPMV are redox-active nanoparticles. The ratio of 
the peak currents is close to unity showing the ferrocene/ferrocenium couple is 
electrochemically reversible. The peak currents were proportional to the square root of the 
scan rate indicating that oxidation and reduction were diffusion controlled [83, 91]. Ferrocene 
dendrimers have shown similar properties due to fast rotation of the dendrimer compared to 
the electrochemical timescale, so that all the redox centres come close to the electrode within 
this timescale [109]. 
 
Over the past few years a large number of biological, organic and inorganic molecules have 
been attached to, especially, wild-type CPMV and mutant virions for different applications 
[110-112], demonstrating that these, and other virus nanoparticles, can be regarded as robust 
and multi-addressable nanobuilding blocks. In a similar fashion to that described for the 
icosahedral viruses, TMV has been used as a scaffold for the selective attachment of 
fluorescent dyes and other small molecules. The native virions offer addressable exterior 
tyrosine residues and interior carboxylates derived from glutamic acid residues [113]. The 
tyrosine residues can be quantitatively functionalised with an alkyne residue by diazonium-
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coupling, then subsequently copper(I)-catalysed azide-alkyne click-chemistry facilitates the 
efficient conjugation of a wide range of compounds [114]. 
 
7 Films, layers and arrays  
The formation of highly ordered nanostructured films, layers and arrays are of great interest 
for the design of novel functional materials that might find applications in, for example, 
sensors, optoelectronics, nanoelectronics and biomedical applications. Virus nanoparticles 
have the capability to self-assemble into discrete particles but show also a propensity for self-
organisation. 
 
Virus crystallisation can lead to the formation of mesoscale self-organisation in three-
dimensions. Icosahedral CPMV particles, for example, can crystallise into well-ordered arrays 
of 1 × 1013 particles in a typical 1 mm3 crystal [102]. CPMV will also self-assemble at the 
interface between two immiscible liquids. The virus particles segregate at a perfluorodecalin-
water interface and stabilise the dispersion of the oil droplets. Cross-linking of the particles at 
the oil-water interface can be achieved with either glutaraldehyde or with biotin/avidin, which 
locks the assembly into place to give a well-defined, robust membrane; the integrity of the 
virus particles are not disrupted [115]. CPMV particles can also be assembled with polyamic 
acid in aqueous solution via the layer-by-layer technique. Then, upon thermal treatment 
CPMV particles are removed and polyamic acid is converted into polyimide in one step, 
resulting in a porous polyimide film [116].  
 
CPMV has been chemically engineered to generate a solvent-free liquid virus, Figure 13 
[117]. The CPMV capsid asymmetric unit contains 51 acidic acid residues (21 glutamic acid 
and 30 aspartic acid). The high anionic charge density was exploited to produce 
stoichiometric constructs capable of undergoing thermally induced melting in the absence of 
water. CPMV was cationised by covalent coupling of ethylenediamine. The cationic-CPMV 
was further modified with anionic polymer-surfactant, poly(ethyleneglycol) 4-nonylphenyl 3-
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sulfoproply ether. Extensive lyophilisation of the single component polymer-surfactant/virus, 
[Cat-CPMV][S], produced a low-density white solid that on thermal annealing melted to a 
viscous translucent fluid that on cooling gave a soft, translucent solid. The ability to prepare 
solvent-free liquids comprising extremely high concentrations of structurally and functionally 
intact virus nanoparticles should have a significant impact in advancing the bioinspired design 
and processing of biologically derived nanostructures [117].  
 
Figure 13  
 
CCMV carries a negative net charge on its outer surfaces at neutral pH (isoelectric point, pI ≈ 
3.8). The negative charge density on CCMV is not homogeneously distributed but is located 
in patches on the capsid surface. The presence of directional ‘sticky patches’ can direct 
nanostructure formation, which is controlled by interactions between the patches [118]. 1-
Pentanethiol-stabilised gold nanoparticles (AuNPs) were mixed with the virus in different pH 
conditions that resulted in various patterns of gold super-lattices adsorbed onto the virus 
capsid [119]. TMV is adsorbed as a monolayer on gold surfaces or hydroxyl containing 
surfaces, such as mica glass and silicon. In addition, covalent immobilisation can be achieved 
utilising acyl chloride that reacts with groups on the virus particles to form ester bonds [120]. 
Genetically modified CCMVCYS and CPMVCYS VNPs which present cysteine-residues on the 
surface, can be readily coupled to patterned gold templates using gold-thiol chemistry [96, 
121]. Combined with nanolithography techniques this approach was utilised to control 
assembly of VNPs [121, 122]. A similar method enables the deposition of a uniform 
monolayer of CPMVCYS mutant particles onto a gold surface; this can be visualised by 
fluorescence microscopy when a suitable dye is conjugated to the virus particles [123]. 
Alternatively, biotinylated-CPMV can be bound easily to streptavidin (SAv) modified 
surfaces [123]. Further, CPMVHIS mutants, that have introduced histidines onto the solvent 
exposed surface, have been discretely immobilised on a NeutrAvidin functionalised surface 
utilising a biotin linker [124]. CPMVHIS can also be reversibly coupled to a nickel-
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nitrilotriacetic acid-terminated nanografted-patterned surface. The attachment/detachment of 
the CPMVHIS is tuneable by variation of conditions such as pH or addition of imidazole. This 
system has provided a means of defining the morphological and assembly kinetics of the 
entropic virus condensation and organisation on the surface as a function of virus 
flux/mobility and inter-virus interaction [125]. 
 
Both CCMV [126] and CPMV [123, 127] 3-dimensional arrays of VNPs were assembled via 
a layer-by-layer approach using the high affinity interaction between biotin and SAv. In the 
case of CCMV, a monolayer of biotinylated-CCMV was electrostatically conjugated to a 
functionalised silicon solid surface [44] and then further layers added [126]. For CPMV, the 
base layer was formed by immobilisation by either direct binding of CPMVCYS particles onto 
gold or indirectly using CPMV-biotin mediated by a thiol-modified SAv. For ease of 
monitoring and tracking the assembly of the layers, one set of virus particles was labelled 
with the fluorescent dye AlexaFluor (AF) 488 and biotin and the another batch with AF568 
and biotin. The first layer of building blocks was assembled with great control using the 
sulfur-gold interaction (SAv-thiol) and further layers by specific interactions between CPMV-
bound-biotin and SAv [123]. The successful assembly process was monitored by fluorescence 
microscopy and quartz crystal microbalance with dissipation monitoring [127]. 
 
Multilayer structures can also be fabricated by the use of electrostatic interactions. The 
electrostatic deposition of oppositely charged polyelectrolyte (polyallylamine and 
polystyrenesulfonate) layers on spherical CarMV particles enabled the polyanion layer to be 
replaced by a monolayer of negatively charged CarMV particles [128]. The virus was 
electrostatically adsorbed onto the positively charged polymer and embeded within it. The 
next deposited layers, of several alternating polyanion and polycation layers, fills holes 
between the virus and restores the surface layer enabling another layer of virus to be 
deposited, Figure 14. The electrostatic interaction of CCMV with various surfaces was also 
investigated [44] led to the construction of alternating polyelectrolyte (polylysine) and CCMV 
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layers [126]. In this case, a cationic polymer layer was sufficient to promote the binding of 
successive layers of CCMV. The layer-by-layer approach has also been used to assemble 
CPMV and TMV into polyelectrolyte substrates [129]. Although CPMV and TMV have 
similar external surface charge and density, as a consequence of their shape, different layer 
architectures were obtained. The sphere-like particles are incorporated into the architecture, 
consistent with the properties of CarMV and CCMV described above, to give a self-
assembled, alternating structure of polyelectrolytes and VNPs. However, in stark contrast, the 
rod-shaped particles are excluded from the arrays and float on top of the polyionic layer 
architecture in an ordered state. This may provide a starting point for the design and 
construction of highly organised virus assemblies bound on polyelectrolyte films.  
 
Figure 14  
 
TMV can be organised and aligned by an alternative slow assembly technique, by pulling a 
meniscus containing the virus suspension over a solid surface, to give a film of controlled 
structure, thickness and long-range virus orientation [130]. The propensity of TMV, at high 
concentration, to self-assemble into a nematic liquid crystal has been exploited to prepare 
mesostructured and mesoporous inverse silica replicas, by controlled sol-gel condensation of 
silicon dioxide on TMV liquid crystals followed by thermal degradation (calcination ) [130, 
131]. Successful replication of the nematic phase requires balancing the rate of organosilane 
reagent hydrolysis and the time for realignment of the TMV after initial mixing. The highly 
ordered, micrometre-sized mesostructures that were obtained consist of a periodic array of co-
aligned, end-to-end joined, TMV particles intercalated with a continuous filament of 
amorphous silica with a periodicity of about 20 nm. Calcination to remove the TMV liquid 
crystal template has a minimal effect on the periodicity of the inverse replica. At lower 
reagent concentrations different nanoparticle forms are obtained that, after calcination, have a 
dense silica core of about 35 nm surrounded by a radial array of linear channels of about 50 
nm length [131].  
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8 Applications of viruses in nanotechnology  
The use of viruses in nanotechnology offers the prospect of rich and diverse technological 
advancements. For example, the deposition of platinum on the TMV capsid surface forms 
nanoparticles with an average diameter of 10 nm [30]. When Pt-TMV was placed between 
two aluminium electrodes, a unique memory effect was observed in which the RNA and the 
TMV capsid acted as charge donor and energy barrier, respectively. When a current was 
applied, the charge transferred from aromatic rings, such as guanine in the RNA, and was 
trapped in the platinum nanoparticles. The reversible charge transfer and charge trapped 
process have created a memory device. Similarly, another memory device was designed using 
CPMV with the exterior capsid modified with quantum dots (QD) [132]. The zinc sulfide 
capped layer of QD acted as charge storage while the aromatic residues (tryptophan) on the 
CPMV capsid acted as a charge transport. Ferromagnetic materials play an important role in 
the development of high-density storage devices, e.g. a computer disk contains a two-
dimensional ferromagnetic thin film, where information is stored. Ferromagnetic 
nanoparticles, like FePt and CoPt [133], have emerged as potential high-density storage 
media. Therefore, the ability to generate highly monodisperse FePt- and CoPt-CPMV might 
be an alternative route to synthesise this type of particle [72], although their physical 
properties are yet to be established. Many VNPs are used to synthesise magnetic and metallic 
nanoparticles of various shapes. Besides, hollow metallic nanoparticles and nanoshells, which 
can differ in their properties, might hold great potential in nanomaterial development. 
 
Furthermore, viruses are considered as naturally biocompatible and biodegradable, which is 
particularly important for medical applications. Plant viruses are less likely to interact with 
human receptors and virus replication or gene expression is not supported in mammalian 
systems [85,134]. Nanoparticles and VNPs are currently under investigation in the field of 
nanomedicine (broadly defined as the application of nanotechnology to medicine) with the 
aim of control of drug delivery, targeting of diseased cells and as imaging agents. VNPs are 
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less likely to interact specifically with the mammalian system and, therefore, are less likely to 
cause potential side effects [135]. For CPMV, it was shown that, even up to dosages of 1016 
CPMV particles/kg body weight, no apparent toxic side effects were observed in mice [136]. 
It has been reported that CPMV and CCMV have a broad biodistribution and were detected in 
a wide variety of tissues throughout the body with no apparent toxic effects [137, 138]. 
CPMV particles mostly accumulated in the liver and spleen [136]. To reduce their 
immunogenicity, VNPs can be PEGylated (modified with polyethylene glycol, PEG) [139-
141]. 
 
VNPs have been modified with fluorophores, quantum dots and metallic nanoparticles, and 
gadolinium complexes have been developed for in vivo imaging agents [105,110, 142, 143]. 
FluorescentCPMV particles allowed high-resolution imaging of major blood vessels to a depth of 
up to 500 µm in comparison to fluorescent-labelled nanospheres [139]. Furthermore, it has 
been shown that Gd3+ can be covalently attached to the exterior or interior surface of viruses 
or electrostatically interacted with the encapsidated RNA molecules [76,144-146] indicating 
that VNPs could serve as excellent candidates for magnetic resonance imaging (MRI) contrast 
agents. 
 
To conclude, in this Chapter it has been described how plant viruses can be utilised for the 
assembly of a wide range of bionanomaterials. The virus particles can be modified on their 
external surface can incorporate material within their capsids, can form films, layers, arrays 
and liquid proteins. The potential for their application is extensive, ranging from new 
materials through novel nanodevices to medical imaging and therapy.  
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Figure Legends 
 
Figure 1 Space filling representation of some plant viruses. Virus structure was generated 
from (http://viperdb.scripps.edu). TMV images were taken from (http://tinyurl.com/nyjmhdp). 
 
Figure 2 Schematic of potential chemical modification sites of an icosahedral plant virus 
capsid: external surface, internal surface, internal loading, external coating 
 
Figure 3 Cryoelectron microscopy reconstructions of CPMV particles. Purified particles were 
flash-frozen in vitreous ice and then subjected to cryoelectron microscopy. (A) reconstruction 
of wild-type CPMV exterior, (B) reconstruction of CPMV VLPs, (C) internal view of CPMV 
VLPs showing empty cavity and (D) wild-type CPMV with encapsidated RNA in blue. 
Images courtesy of Dr Kyle Dent and Dr Neil Ranson, University of Leeds, United Kingdom. 
 
Figure 4 Assembly of RCNMV VLPs around a gold nanoparticle via OAS templating. (A) 
conjugation of nanoparticle with DNA-2; (B) addition of RNA-1, which interacts with DNA-
2 to form the functional OAS; (C) the artificial OAS templates the assembly of coat protein; 
and (D) formation of virus-like particle with nanoparticle encapsidated. Reprinted with 
permission from Loo, et al., J. Am. Chem. Soc. (2006) 128, 4502. Copyright 2006 American 
Chemical Society. 
 
Figure 5 Proposed mechanism of VLP assembly from coat proteins. (a) Electrostatic 
interaction leads to the formation of disordered protein-gold nanoparticle complexes. The 
second step is a crystallization phase in which the protein-protein interactions lead to the 
formation of a regular capsid. (b) Schematic depiction of the encapsidated nanoparticle 
functionalised with carboxyl-terminated PEG chains. Right: Cryoelectron micrograph of a 
single VLP shows the protein structure coating the 12 nm diameter gold nanoparticle (black 
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disk). Reprinted with permission from Chen, et al., Nano Letters (2006) 6, 611. Copyright 
2006 American Chemical Society. 
 
Figure 6 Cryoelectron microscopy and image reconstruction of Cowpea chlorotic mottle 
virus. In an unswollen condition induced by low pH (on the left) and in a swollen condition 
induced by high pH (on the right). Swelling at the pseudo-three-fold axis results in the 
formation of sixty 2 nm pores. Reprinted by permission from Macmillan Publishers Ltd: 
Nature, Douglas and Young (1998) 393, 152, Copyright (1998). 
 
Figure 7 The structure of Cowpea mosaic virus (CPMV) capsid and the asymmetric unit. 
CPMV capsid is comprised of small (S) and large (L) sub-units. The A domain (in blue), B 
domain (in green) and C domain (in yellow). Adapted from Steinmetz and Evans, Org. 
Biomol. Chem. (2007) 8, 1131 - Reproduced by permission of The Royal Society of 
Chemistry.  
 
Figure 8 Separation of the different components of Cowpea mosaic virus. (A) In a caesium 
chloride gradient by ultracentrifugation (B) Electrophoretic travel of particles containing the 
different forms of the S subunit, the slow (s) and the fast (f). Images in (A) courtesy of Dr. 
Keith Saunders, John Innes Centre, United Kingdom.  
 
Figure 9 Stained TEM image of a single tessellated-sphere showing the CPMV particles as 
hexagonally packed mosaic pieces in a spherical arrangement together with gold 
nanoparticles that appear as black circles. Reprinted with permission from Aljabali, et al., 
Biomacromolecules (2011) 12, 2723. Copyright 2011 American Chemical Society. 
 
Figure 10 Loading of CPMV VLPs with cobalt. (A) Agarose gel of wild-type and 
LD4His VLPs subjected to the cobalt loading reaction. Wild-type VLPs were subjected to 
cobalt loading with (+ve) and without (−ve) pre-treatment with chymotrypsin. CPMV virions 
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(CPMV) and top components (Top) were electrophoresed as controls. The gel was stained 
with Coomassie brilliant blue. (B) Representation of the pattern of mineralization of VLP 
variants showing dynamic light scattering measurements taken after the cobalt loading 
reaction: –ve shows no mineralization, +ve is internally mineralized, and LD4His is 
externally mineralized. Reprinted with permission from Sainsbury, et al., ChemBioChem 
(2011) 12, 2453. Copyright 2011 Viley-VCH Verlag GmbH & Co. 
 
Figure 11 Schematic representation of the surface exposed addressable amines and 
carboxylates of the CPMV capsid. Adapted from Steinmetz and Evans, Org. Biomol. Chem. 
(2007) 8, 1131 - Reproduced by permission of The Royal Society of Chemistry. 
 
Figure 12 TEM image of HRP–ADHCPMV particles stained with 1% AgNO3 solution that stains 
specifically the generated aldehyde groups as a result of the oxidation process confirming the 
presence of enzyme. Inset confirms the localization of the metallic silver on the virus capsid. 
Adapted from Aljabali et al., Nanoscale (2012), 4, 5640 - Reproduced by permission of The 
Royal Society of Chemistry. 
 
Figure 13 Optical photographs of sample tubes containing [Cat-CPMV][S] showing a low 
density white solid obtained after lyophilization (A) and a highly viscous translucent fluid 
obtained after annealing the freeze-dried material at 65 °C for 10 minutes (B). (C) Optical 
image showing single liquid droplet of a solvent-free [Cat-CPMV][S] melt placed on a glass 
slide at 65 °C. Reprinted with permission from Patil, et al., Advanced Materials (2012) 24, 
4557. Copyright 2012 Viley-VCH Verlag GmbH & Co. 
 
Figure 14 The deposition process of alternate layers of polyelectrolytes and Carnation mottle 
virus (CarMV). (a) Smooth polyelectrolyte precursor film. (b) Adsorbed virus particles 
partially intrude into the polymer layer. (c) The next polymer layer fills the empty space 
between the viruses and leads to a partial annealing of the surface. (d) Further polymer layers 
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completely anneal the surface so as to give conventional roughness and layer thickness. 
Reprinted with permission from Lvov et al., Langmuir, (1994), 10, 4232. Copyright 1994 
American Chemical Society. 
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